nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—SLC6A4—conduct disorder	0.926	1	CbGaD
Chlorphenamine—SLC6A3—Clearance of dopamine—COMT—conduct disorder	0.00805	0.115	CbGpPWpGaD
Chlorphenamine—SLC6A3—Clearance of dopamine—MAOA—conduct disorder	0.00799	0.115	CbGpPWpGaD
Chlorphenamine—SLC6A4—Serotonin Transporter Activity—MAOA—conduct disorder	0.00371	0.0532	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00367	0.0527	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.00365	0.0523	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00334	0.0479	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.00332	0.0476	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00311	0.0447	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.00309	0.0443	CbGpPWpGaD
Chlorphenamine—SLC6A2—Monoamine Transport—SLC6A4—conduct disorder	0.0018	0.0259	CbGpPWpGaD
Chlorphenamine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00173	0.0249	CbGpPWpGaD
Chlorphenamine—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00162	0.0232	CbGpPWpGaD
Chlorphenamine—SLC6A3—Monoamine Transport—SLC6A4—conduct disorder	0.0016	0.0229	CbGpPWpGaD
Chlorphenamine—HRH1—Monoamine GPCRs—DRD4—conduct disorder	0.00116	0.0166	CbGpPWpGaD
Chlorphenamine—HRH1—Amine ligand-binding receptors—DRD4—conduct disorder	0.000972	0.0139	CbGpPWpGaD
Chlorphenamine—Promazine—DRD4—conduct disorder	0.000911	0.213	CrCbGaD
Chlorphenamine—SLC22A2—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00088	0.0126	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00082	0.0118	CbGpPWpGaD
Chlorphenamine—Chlorpromazine—DRD4—conduct disorder	0.000802	0.187	CrCbGaD
Chlorphenamine—HRH1—Monoamine GPCRs—HTR2A—conduct disorder	0.000754	0.0108	CbGpPWpGaD
Chlorphenamine—Clomipramine—SLC6A4—conduct disorder	0.000702	0.164	CrCbGaD
Chlorphenamine—HRH1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000634	0.00909	CbGpPWpGaD
Chlorphenamine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000609	0.00874	CbGpPWpGaD
Chlorphenamine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000588	0.00843	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000581	0.00833	CbGpPWpGaD
Chlorphenamine—Clomipramine—HTR2A—conduct disorder	0.000539	0.126	CrCbGaD
Chlorphenamine—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000537	0.00771	CbGpPWpGaD
Chlorphenamine—Chlorprothixene—HTR2A—conduct disorder	0.000537	0.125	CrCbGaD
Chlorphenamine—SLC6A2—NRF2 pathway—SLC6A4—conduct disorder	0.000536	0.00768	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000529	0.00758	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000493	0.00707	CbGpPWpGaD
Chlorphenamine—SLC6A3—NRF2 pathway—SLC6A4—conduct disorder	0.000475	0.00681	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—DRD4—conduct disorder	0.000453	0.0065	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—GABRA2—conduct disorder	0.000445	0.00638	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000445	0.00638	CbGpPWpGaD
Chlorphenamine—Promazine—HTR2A—conduct disorder	0.00042	0.0981	CrCbGaD
Chlorphenamine—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.000405	0.00581	CbGpPWpGaD
Chlorphenamine—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000388	0.00557	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.000377	0.00541	CbGpPWpGaD
Chlorphenamine—Chlorpromazine—HTR2A—conduct disorder	0.00037	0.0864	CrCbGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000362	0.0052	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000341	0.00489	CbGpPWpGaD
Chlorphenamine—CYP3A7—Biological oxidations—COMT—conduct disorder	0.000287	0.00412	CbGpPWpGaD
Chlorphenamine—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.000285	0.00409	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.000283	0.00407	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00028	0.00401	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000278	0.00398	CbGpPWpGaD
Chlorphenamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000276	0.00396	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00027	0.00387	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.000269	0.00386	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CGA—conduct disorder	0.00026	0.00373	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000254	0.00365	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000253	0.00362	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000239	0.00343	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000237	0.0034	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000235	0.00338	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000223	0.0032	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000218	0.00312	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—COMT—conduct disorder	0.000214	0.00307	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—MAOA—conduct disorder	0.000213	0.00305	CbGpPWpGaD
Chlorphenamine—CYP3A5—Biological oxidations—COMT—conduct disorder	0.000208	0.00298	CbGpPWpGaD
Chlorphenamine—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.000206	0.00296	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.000205	0.00294	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000203	0.00291	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—COMT—conduct disorder	0.000195	0.0028	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—MAOA—conduct disorder	0.000194	0.00278	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000192	0.00275	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000191	0.00274	CbGpPWpGaD
Chlorphenamine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000188	0.0027	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—COMT—conduct disorder	0.000182	0.00261	CbGpPWpGaD
Chlorphenamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000181	0.00259	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00018	0.00259	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000168	0.00242	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	0.000157	0.00225	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000148	0.00212	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000147	0.00211	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000147	0.0021	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000146	0.00209	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000146	0.00209	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000146	0.00209	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CGA—conduct disorder	0.000133	0.00191	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000125	0.00179	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CGA—conduct disorder	0.000109	0.00156	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CGA—conduct disorder	0.000109	0.00156	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CGA—conduct disorder	0.000101	0.00145	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—COMT—conduct disorder	9.66e-05	0.00139	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—MAOA—conduct disorder	9.59e-05	0.00138	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	9.53e-05	0.00137	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	9.5e-05	0.00136	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	8.22e-05	0.00118	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CGA—conduct disorder	7.88e-05	0.00113	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CGA—conduct disorder	7.87e-05	0.00113	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—DRD4—conduct disorder	7.47e-05	0.00107	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—WASF1—conduct disorder	6.31e-05	0.000906	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CGA—conduct disorder	5.6e-05	0.000803	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	5.37e-05	0.00077	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—COMT—conduct disorder	4.92e-05	0.000705	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—COMT—conduct disorder	4.91e-05	0.000704	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—MAOA—conduct disorder	4.88e-05	0.0007	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—MAOA—conduct disorder	4.87e-05	0.000699	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	4.87e-05	0.000699	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—COMT—conduct disorder	4.57e-05	0.000656	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—MAOA—conduct disorder	4.54e-05	0.000652	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DRD4—conduct disorder	4.41e-05	0.000633	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CGA—conduct disorder	3.66e-05	0.000525	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—COMT—conduct disorder	3.55e-05	0.00051	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—MAOA—conduct disorder	3.53e-05	0.000506	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HTR2A—conduct disorder	2.88e-05	0.000413	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—COMT—conduct disorder	2.53e-05	0.000362	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—MAOA—conduct disorder	2.51e-05	0.00036	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—EP300—conduct disorder	2.11e-05	0.000302	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—EP300—conduct disorder	2.1e-05	0.000302	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—EP300—conduct disorder	1.96e-05	0.000281	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—COMT—conduct disorder	1.65e-05	0.000237	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—MAOA—conduct disorder	1.64e-05	0.000235	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—EP300—conduct disorder	1.53e-05	0.000219	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—EP300—conduct disorder	1.52e-05	0.000219	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—EP300—conduct disorder	1.08e-05	0.000155	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—EP300—conduct disorder	7.08e-06	0.000102	CbGpPWpGaD
